Sera Prognostics (SERA)
(Delayed Data from NSDQ)
$8.03 USD
+0.12 (1.52%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $8.02 -0.01 (-0.12%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth C Momentum D VGM
Price, Consensus and EPS Surprise
SERA 8.03 +0.12(1.52%)
Will SERA be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for SERA based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for SERA
Encompass Health (EHC), Piedmont Expand Ties to Serve Georgia
Teladoc (TDOC) Harnesses AI for Diabetes Care, Stock Rises 6.7%
SERA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Elevance Health (ELV) Rallies 11.8% YTD: More Room to Run?
Brookdale (BKD) Sees 31 Months of Y/Y Occupancy Growth Streak
Select Medical (SEM) Rises 42.4% YTD: More Growth Ahead?
Other News for SERA
Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2024 Financial Results on August 7, 2024
Sera Prognostics PreTRMĀ® Test Prevention Strategy Demonstrates 18% Reduction in Severe Neonatal Morbidity and Mortality in Newly Published AVERT Trial
3 Stocks Under $10 With the Potential to Make You a Millionaire
SERA PROGNOSTICS EXPECTED TO BE ADDED TO RUSSELL 2000 AND 3000 INDEXES
Sera Prognostics set to be added to Russell 2000, 3000 indexes